Robert Dreicer

Robert DreicerRobert Dreicer, MD, MS, FASCO, MACP received his medical degree from the University of Texas-Houston and a Master of Science from the University of Texas Graduate School of Biomedical Sciences. Following his oncology fellowship, he joined the facultyat University of Iowa, achieving tenure and serving as the associate director of the division of haematology/oncology. He was recruited to Cleveland Clinic, where he served as chair of the department of solid tumor oncology from 2006-2014, before joining UVA Cancer Center in 2015. His research interests are in novel therapeutic approaches for urologic cancer including prostate, urothelial and kidney cancers. He serves as member of the Medical Oncology Test Writing Committee of the American Board of Internal Medicine and is member of the editorial board of New England Journal of Medicine's Journal Watch Hematology/Oncology. Dreicer has been named for many years to Top Doctors in America, America's Best Doctors and America's Top Doctors for Cancer. Read More Read Less

1 results found
List viewGrid view
Sort By:
1.
Btk Inhibitors as Sensitizing Agents in Solid Tumors2 % NR
Publisher: Elsevier Science
No Review Yet
₹14,700
₹14,406
Binding:
Hardback
Release:
01 Nov 2022
Language:
English
Out of Stock
Notify me when this book is in stockNotify Me
No more records found